Information for Clinicians on Investigational Therapeutics for Patients with COVID-19: April 25, 2020

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated April 25, 2020 ; There are no drugs or other therapeutics presently approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. Current clinical management includes infection prevention and control measures and supportive care, including supplemental oxygen and mechanical ventilatory support when indicated. ; The National Institutes of Health have published interim guidelines for the medical management of COVID-19external icon prepared by the COVID-19 Treatment Guidelines Panel. ; These guidelines contain information about investigational therapeutics and will be updated as new information emerges and drugs and other therapeutic interventions are approved for use by FDA. ; Persons seeking information about registered clinical trials for COVID-19 in the United States can search for such information here: ClinicalTrials https://clinicaltrials.gov
• Subjects:
  • COVID-19
  • Coronavirus Infections/drug therapy
  • Coronavirus Infections/therapy
• Series:
  Coronavirus Disease 2019 (COVID-19)
• Document Type:
  Text
• Download URL:
  https://stacks.cdc.gov/view/cdc/87217/cdc_87217_DS1.pdf
• File Type:
  [PDF - 57.82 KB]
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:8c9c1bef2094a5f296f94dd3cfa44bdb37a56635c4e79414f78631e238ff4ed9bf23d06ded90469025615c569c1e353cb05b5c56a50b3b3bc8fd88c28be9526a